New drug molidustat tracked in 1,000+ kidney anemia patients
NCT ID NCT04899661
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 24 times
Summary
This study follows over 1,000 Japanese adults with renal anemia—a condition where the kidneys don't produce enough hormone to make red blood cells—who are taking the drug Molidustat. Researchers are monitoring safety and whether the drug boosts red blood cell counts over up to 2 years. The goal is to see how well Molidustat works in everyday medical practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Many facilities
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.